Breaking News

Pharmaceutical Research and Manufacturers of America v. McClain

Share
Petition for certiorari denied on December 9, 2024
Docket No. Op. Below Argument Opinion Vote Author Term
24-118 8th Cir. N/A N/A N/A N/A OT 2024

Issue: Whether the U.S. Court of Appeals for the 8th Circuit erred in holding that a state may strip manufacturers of the ability preserved to them by the federal 340B Drug Pricing Program to impose conditions on the use of contract pharmacies as part of the offer to provide 340B-priced drugs and intrude on 340B’s centralized enforcement scheme.

SCOTUSblog Coverage

DateProceedings and Orders (key to color coding)
Jul 31 2024Petition for a writ of certiorari filed. (Response due September 3, 2024)
Aug 20 2024Motion to extend the time to file a response from September 3, 2024 to November 4, 2024, submitted to The Clerk.
Aug 21 2024Motion to extend the time to file a response is granted and the time is extended to and including November 4, 2024.
Sep 03 2024Brief amicus curiae of Kalderos, Inc. filed.
Nov 04 2024Brief of respondents Community Health Centers of Arkansas and Piggott Community Hospital in opposition filed.
Nov 04 2024Brief of respondent Alan McClain, Commissioner of the Arkansas Insurance Department, in opposition filed.
Nov 19 2024DISTRIBUTED for Conference of 12/6/2024.
Nov 19 2024Reply of petitioner Pharmaceutical Research and Manufacturers of America filed. (Distributed)
Dec 09 2024Petition DENIED.